Skip to main content
BIOVENTIX PLC logo

BIOVENTIX PLC — Investor Relations & Filings

Ticker · BVXP ISIN · GB00B4QVDF07 LEI · 213800225MHX7LZQY108 IL Manufacturing
Open in API
Filings indexed 211 across all filing types
Latest filing 2018-02-13 Major Shareholding Noti…
Country GB United Kingdom
Listing IL BVXP

About BIOVENTIX PLC

https://www.bioventix.com/

Bioventix PLC is a biotechnology company that specializes in the development, creation, and commercial supply of high-affinity sheep monoclonal antibodies (SMAs). These antibodies are utilized by global diagnostic companies as critical components in clinical diagnostic platforms, particularly for blood testing immunoassays. The company's portfolio supports a variety of applications, including diagnostics for cardiovascular conditions (troponin), oncology, and neurodegenerative diseases such as Alzheimer's. In addition to its core antibody products, Bioventix also provides ELISA kits for monitoring exposure to industrial pollutants and offers contract services for the development of new SMAs for healthcare organizations.

Recent filings

Filing Released Lang Actions
Bioventix Plc - Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains structured fields detailing the 'NOTIFICATION OF MAJOR HOLDINGS' for BIOVENTIX PLC by 'MITON GROUP PLC'. It specifies the date the threshold was crossed (09/02/2018) and reports the resulting percentage of voting rights (10.95%). This format and content directly correspond to regulatory filings concerning changes in significant share ownership, which aligns with the definition for Major Shareholding Notification (MRQ).
2018-02-13 English
Bioventix Plc - Result of AGM
AGM Information Classification · 99% confidence The document explicitly states in the title and body that it is the "Result of AGM" (Annual General Meeting). It confirms that "all resolutions put to shareholders were duly passed." This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to an AGM, the core content is the result of the vote, not the presentation materials (AGM-R) or the proxy solicitation (PSI). The document is short and serves as a formal announcement of the voting outcome.
2017-12-18 English
Full accounts made up to 2017-06-30
Regulatory Filings
2017-11-30 English
Bioventix Plc - Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'Bioventix Plc - Director/PDMR Shareholding' and details transactions (sales) of ordinary shares by the Non-Executive Chairman (Ian Nicholson) and the CEO (Peter Harrison), along with persons closely associated with them. This explicitly falls under the category of reporting personal share transactions by company directors and executives (insider trades). This matches the definition for Director's Dealing (DIRS). The document structure, including tables detailing price, volume, and resulting holdings, confirms this is a specific regulatory disclosure regarding insider transactions, not a general earnings release or annual report.
2017-10-20 English
Bioventix Plc - Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains structured fields detailing an 'acquisition or disposal of voting rights' by 'CASTLEFIELD FUND PARTNERS LIMITED' in 'BIOVENTIX'. This form (TR-1) is the standard regulatory notification required in the UK/EU when an investor's holding crosses a major threshold (in this case, reaching 8.07%). This directly corresponds to the definition of Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since this is a notification of a change in significant share ownership by an entity (not necessarily a director, but a major shareholder), the most appropriate classification is Major Shareholding Notification (MRQ).
2017-10-20 English
Bioventix Plc - Final Results
Earnings Release Classification · 100% confidence The document explicitly states it contains 'Bioventix Plc - Final Results' and provides 'audited results for the year ended 30 June 2017'. It includes a full Statement of Comprehensive Income and a Statement of Financial Position for the year, along with detailed business reviews and dividend announcements. This structure and content strongly indicate a comprehensive annual financial report. Although it is presented as a press release/announcement, the inclusion of the full financial statements (Turnover, Profit before tax, Balance Sheet) means it functions as the primary Annual Report disclosure, which aligns best with the '10-K' classification for official yearly reports, even if the specific SEC form name isn't used (as this is a UK company). Given the depth of financial data, it is not merely an Earnings Release (ER) or a Report Publication Announcement (RPA). FY 2017
2017-10-16 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.